Quantifying the natural growth rate of hepatocellular carcinoma: A real-world retrospective study in southwestern China

Table 1 Patient characteristics of the study population, n (%)

Variable	Total (n = 60)
Age	60.0 ± 11.1
Sex
Female	11 (18.3)
Male	49 (81.7)
Smoking
No	24 (40.7)
Yes	35 (59.3)
Drinking
No	27 (45.8)
Yes	32 (54.2)
BMI	23.8 ± 3.1
Hepatitis
Non-HBV	8 (13.3)
HBV	52 (86.7)
AFP, median (IQR)	14.3 (3.1, 120.4)
AVD, median (IQR)	21.8 (15.2, 39.6)
Child-Pugh (%)
A	20 (33.3)
B	31 (51.7)
C	6 (10.0)
NA1	3 (5.0)
BCLC classification
A	26 (43.3)
B	22 (36.7)
C	6 (10.0)
D	3 (5.0)
NA1	3 (5.0)

¹Missing data.

AVD: Average diameter; BMI: Body mass index; HBV: Hepatitis B virus; AFP: Alpha-fetoprotein.

Table 2 Tumor growth feature of the study patient

Variable	Total (n = 60)
TVDT, median (IQR)	163.4 (72.1, 302.3)
TGR, median (IQR)	42.4 (23.0, 96.1)

TVDT: Tumor volume doubling time; TGR: Tumor growth rate; IQR: Interquartile range.